Members area login




Please enter your email address


Please enter your membership ID (optional)

Follow Cephalalgia
Follow IHS

About the IHS

  • M G Bousser (France)

    Marie-Germaine Bousser is Professor of Neurology at Paris Diderot University in France and  former head of Neurology Department in Lariboisière Hospital in Paris.

    She has been one of the founding members of the European Stroke Conference (1990) and the President and founder of the French Stroke Society (1996-1998). She has also been  President of the French Headache Society (1995-1998) and of the International Headache Society (1995-1997).

    After a thesis devoted to the prevention of cerebral artery thrombosis in the rabbit by aspirin and prostaglandin E1, Professor Bousser's research  has been clinically orientated and has mainly dealt with vascular neurology and migraine about which  she wrote over 400 papers and 8 books , with the following six main topics of interest:  
    1- Stroke prevention : she was the principal investigator of  the French AICLA Study (1983) , the second ever trial to demonstrate the efficacy of aspirin in secondary  stroke prevention and she was member of executive committees of many stroke  prevention trials (CAPRIE, ECST, PROGRESS, AMADEUS, PERFORM...)
    2- CADASIL, which she identified in 1993 in a single French family in collaboration with her co-worker geneticist Pr E. Tournier-Lasserve , and which is now known to affect over 600 families worldwide. This has been a major breakthrough in the understanding of small arteries diseases of the brain and of vascular dementia.
    3- Cerebral venous thrombosis : based on a personal series of 450 patients, Pr Bousser has written many papers and a book on various aspects of CVT presentation , diagnosis and treatment.. She is one of the coordinators of the ISCVT registry.
    4- Migraine and stroke : her team showed that migraine with aura is a risk factor for cerebral infarction in young women, particularly if they smoke or use oral contraceptives.
    5- Cervical artery dissections: she wrote over 20 papers on dissections and showed for the first time a statistical association between migraine and dissections.
    6- Familial hemiplegic migraine : Her group demonstrated the first location (on chromosome 19) of one the FHM genes, found a second gene location (on chromosome 1) and studied the phenotype-genotype correlations associated with mutations in FHM1 gene

    To recognize her achievements in stroke research, Professor Bousser was awarded the 2008 Johann Jakob Wepfer Prize given by the European Stroke Conference.

  • John Desmond Carroll (UK) Deceased
  • Hans-Christoph Diener Special Recognition Award (Germany)

    Hans-Christoph Diener, MD, PhD is affiliated with the Institute for Epidemiology at the University Duisburg-Essen. He was Professor of Clinical Neurosciences at the Medical Faculty of the University Duisburg-Essen from 2016-2019. He was Professor of Neurology, Chairman of the Department of Neurology and Director of the Essen Headache Centre at the University of Duisburg-Essen in Germany from 1989 to 2016. He was President of the German Neurological Society, President of the European Headache Federation (EHF), and the International Headache Society and chaired the German Headache Consortium

    Professor Diener received his medical degree and doctorate at the Albrecht-Ludwigs-Universität in Freiburg, and continued his training there in the Departments of Neurology, Psychiatry, Internal Medicine and Surgery. Prior to joining the University of Essen in 1989, he was an Associate Professor of Neurology at the Department of Neurology at the University of Tübingen. He was a visiting Professor at the Neurological Sciences Institute in Portland, Oregon in 1984 and 1985 and at the University of New South Wales in Sydney in 1987 and 1988.

    Professor Diener has been the PI in more than 30 trials on the acute treatment and prophylaxis of headache disorders.

    Professor Diener has authored or co-authored 962 articles in peer reviewed journals (192 as first author, 21 in the NEJM), 352 invited reviews, and 367 book chapters, and served as the editor or author of 84 books. His h index is 120. He is the editor of Neurology Up2date, Arzneimitteltherapie, Info Neurologie & Psychiatrie, deputy editor of Cephalalgia, Stroke Editor for Current Neurology and Neurosciences Reviews and serves on the editorial boards of Lancet Neurology and Cerebrovascular Diseases.

    In the last 3 years HCD received honoraria for participation in clinical trials, contribution to advisory boards or oral presentations from: Allergan, Amgen, Electrocore, Lilly, Novartis, Teva,Weber & Weber and WebMD. HCD has no ownership interest and does not own stocks of any pharmaceutical company. HCD serves on the editorial boards of Cephalalgia and Lancet Neurology. HCD chairs the Clinical Guidelines Committee of the German Society of Neurology and is a member of the Clinical Trials Guideline Committee of the IHS.

  • David William Dodick (USA)

    David W Dodick, MD, FRCP (C), FACP, is Professor of Neurology at the Mayo Clinic College of Medicine and a consultant in neurology at the Mayo Clinic, in Scottsdale, Arizona. He is the Director of the Headache Program and the Sports Neurology and Concussion Program at Mayo Clinic in Arizona. Dr Dodick is board certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Psychiatry and Neurology (ABPN). He also holds United Council for Neurologic Subspecialties certification in headache medicine and ABPN certification in vascular neurology.

    Dr Dodick has authored more than 350 peer-reviewed publications and authored/edited 10 books. He is the Chair of the Sports Concussion Conference Workgroup and the AAN Annual Sports Concussion Conference of the American Academy of Neurology and a member of the AAN’s Annual Meeting Committee. He is a member of the scientific committee of the International Migraine Trust. He is Chair of the International Headache Academy. He is on the editorial board of several journals including Lancet Neurology, Journal of Neurology, Neurosurgery and Psychiatry, Postgraduate Medicine, Headache, and Cephalalgia.

    He is Past-President of the International Headache Society, Past President of the American Headache Society, Chair of the American Migraine Foundation, Director of the US Academic Headache Consortium, and past-Editor-in-Chief of Cephalalgia.

    Consulting: Acorda, Allergan, Amgen, Alder, Promius, eNeura, Eli Lilly & Company, Insys therapeutics, Autonomic Technologies, Teva, Xenon, Tonix, Trigemina, Boston Scientific, GBS, Colucid, Zosano, Laydenburg Thalmann, Biocentric, Biohaven, Magellan, Charleston Laboratories, Theranica.
    Royalties: Oxford University Press and Cambridge University Press (Book Royalty).
    Editorial/honoraria from UpToDate, Chameleon Communications, Medscape, WebMD, Academy for Continued Healthcare Learning, Haymarket Medical Education, Global Scientific Communications, HealthLogix,
    Academy for Continued Healthcare Learning, MeetingLogiX, Wiley Blackwell, Oxford University Press, Cambridge University Press. Stock/options: GBS/Nocira, Epien, Healint, and Mobile Health. Consulting use
    agreement: NAS. Board position: King-Devick Inc.

  • Karl Ekbom (Sweden)
  • Michel D Ferrari (Netherlands)

    Michel D Ferrari, MD, PhD, is Professor of Neurology and Chair of the Leiden Centre for Translational Neuroscience at Leiden University Medical Centre (LUMC).

    He received his MD in 1980, his specialty certificates in Neurology and Clinical Neurophysiology in 1985, and his Ph.D. on "Serotonin and Migraine" in 1992 cum laude from LUMC (supervisors Profs. GW Bruyn & PR Saxena). He was a Research Fellow at Baylor College of Medicine, Houston with Professor KMA Welch, and at Harvard Medical School with Professor MA Moskowitz.

    Michel Ferrari is a corresponding member of the American Neurological Association, Honorary Member of IHS and the Italian Headache Society, and has received numerous awards including the Arnold Friedman Distinguished Clinician Researcher (1995) and the Harold G Wolff (1997) Awards from the American Headache Society, the Migraine Trust (2002), the European Headache Federation (2006), and the IHS Special (2009) Lectures, and the three-annually Hartmann Muller Prize for Biomedical Research from the University of Zurich (2011). In 2005 the Dutch Neurological Association awarded him with the five-annually Winkler Medallion for Excellence in Neurological Research and in 2004 The Netherlands Organisation for Scientific Research (NWO) gave him the prestigious Vci Innovational Research Personal Incentive Schema Award and in 2009 the Spinoza Life Time Achievement Premium, the highest science prize in The Netherlands, also known as the Dutch Nobel prize.

    Michel Ferrari is the PI of several international consortia, including the FP6 EUROHEAD programme, in which nine European centres collaborate to decipher the molecular neurobiology of migraine. He serves on executive and scientific boards of many scientific organisations, is associate editor of Cephalalgia, Eur J Neurology and Headache Currents, and is a regular reviewer for many prestigious scientific journals. He has organised several congresses, including the 1997 IHS World Congress in Amsterdam, and has authored many books and over 425 peer-reviewed publications on the neurobiological, genetic, and clinical aspects of migraine, cluster headache syndromes, ataxia, and epilepsy. He ranks among the top three most cited scientists on 'Migraine and Other Vascular Headaches'. His paper on the first migraine gene (Cell 1996) is the highest cited paper in the field.

  • Peter J Goadsby Special Recognition Award (UK)

    Peter Goadsby obtained his medical degree and training at the University of New South Wales (UNSW), Australia. Neurology training was with James W. Lance and clinical neurophysiology with David Burke. After post-doctoral work in New York with Don Reis at Cornell, Jacques Seylaz at Universite VII, Paris, and post-graduate neurology training at Queen Square, London with C David Marsden, Andrew Lees, Anita Harding and W Ian McDonald, he returned to UNSW, and the Prince of Wales Hospital, Sydney as a consultant neurologist and became an Associate Professor of Neurology. He was appointed a Wellcome Senior Research Fellow at the Institute of Neurology, University College London in 1995. He was Professor of Clinical Neurology and Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London until 2007.

    He has been Professor of Neurology, Department of Neurology, University of California, San Francisco since 2007. He has been an Honorary Consultant Neurologist at the Hospital for Sick Children, Great Ormond St, London since 1998.

    In 2013 he was appointed Director, NIHR-Wellcome Trust King’s Clinical Research Facility, King’s College Hospital, Professor of Neurology at King’s College London and Honorary Consultant Neurologist, King’s College Hospital.

    His major research interests are in the basic mechanisms of primary headache disorders, such as migraine and cluster headache, in both experimental and clinical settings, and translating these insights into better management. 

    Dr Goadsby reports personal fees from Alder Biopharmaceuticals, personal fees from Allergan, grants and personal fees from Amgen, personal fees from Autonomic Technologies Inc., personal fees from Biohaven Pharmaceuticals Inc., grants and personal fees from Eli Lilly and Company, personal fees from Electrocore LLC, personal fees from eNeura Inc, personal fees from Impel Neuropharma, personal fees from MundiPharma, personal fees from Novartis, personal fees from Teva Pharmaceuticals, other from Trigemina, personal fees from WL Gore, personal fees from Gerson Lehrman Group, personal fees from Guidepoint,  outside the submitted work;  In addition, Dr Goadsby has a patent Magnetic stimulation for headache licensed to eNeura without fee and Fees for publishing from Oxford University Press, Massachusetts Medical Society, Wolters Kluwer and for medicolegal work.

  • Eero Hokkanen (Finland)

    Eero Hokkanen was born in Hämeenlinna Finland in 1931. He first enrolled to study law but soon changed into medicine, graduating from the University of Helsinki in 1958. Postgraduate studies and training in neurology took place at the Helsinki University Central Hospital as well as London University, Institute of Neurology (at Queen Square) in UK. In 1964 Professor Hokkanen finished his specialist degree (state examination in Finland) in neurology. He completed his PhD on neurology for the Doctorate in Medical Sciences in 1969. Later he completed degrees also in healthcare administration in 1979, neurogeriatrics (subspeciality of neurology) in 1984, as well as geriatrics (independent speciality) in 1985.

    Eero Hokkanen held senior positions in neurology at the Department of Neurology of the Helsinki University Central Hospital during 1965-1969. In 1970 he was elected Professor of Neurology and Head of the University Department of Neurology, University of Oulu, in northern Finland. There he stayed for 17 years during which he also acted as the Leading Chief Physician of the Oulu University Hospital from 1976-1981.

    In 1987 Professor Hokkanen was appointed as the Director of the Department of Hospital Care at the National Board of Health, an agency directly under the Ministry of Social Affairs and Health in Helsinki.  After this in 1991 Hokkanen started working as the Deputy Director General of the National Agency for Welfare and Health and the Director of its Welfare and Health Services Department and in 1992 he became the Deputy Director General at the Ministry of Social Affairs and Health (working especially for its Department for Social and Health Services). At the end of 1994 he retired.

    Professor Hokkanen´s research from 1964 onwards was first focused on neuromuscular diseases (thesis in 1969). Very soon the main focus became directed to the many problems of headaches and especially migraine and in 1969 he was the promoter in founding the Finnish Migraine Society in Helsinki. He attended the first Scandinavian meeting on migraine held in Copenhagen in 1969, and next year the Finnish Migraine Society became full member of the Scandinavian Migraine Society. In the Finnish Migraine Society he served as Secretary from 1970-1973 and Chairman from 1973-1994, and in the Scandinavian Migraine Society as board member from 1970-1994 and as President from 1975-1976, 1981-1983 and 199-1991. In June 1976 a very successful joint meeting of the Italian Headache Society (with F Sicuteri as President) and the Scandinavian Migraine Society (E Hokkanen as President) was arranged in Florence, Italy.

    Eero Hokkanen was also a very active member of the WFN Research Group on Migraine and Headache during the years 1984-1994. He became the Board Member of the new International Headache Society in 1982 and during its first Congress in Munich 1983 Professor Hokkanen was elected for the Presidency of IHS. He served as the President from 1983-1985 and as a member of  the Executive Committee from 1983-1987. During 1983-1985 the new Constitution of the International Headache Society was discussed, prepared, approved, and finally signed by the Eero Hokkanen as IHS President and the IHS General Secretary, Volker Pfaffenrath. During 1991-1993 he was also a Board Member of the new European Headache Federation. In 1997 Professor Hokkanen became an honorary member of IHS.

    Throughout his career Eero Hokkanen has also been active in the World Federation of Neurology (WFN). He was a member of the Council of National Delegates from 1975-1981, and a member of the Research Group of Migraine and Headaches from 1984-1994. He was also Chairman of the FN Nomination Committee during two consecutive 4-years periods, from 1989-1993 and 1993-1997. Following that he was elected as a member of the Steering Committee from 1998-2001.

    After having been appointed to work within the agencies of Ministry of Social Affairs and Health in 1987, Professor Hokkanen´s focus of interest broadened into national health problems. He became engaged in working in high positions of trust in numerous national and regional committees and working groups within healthcare and welfare in Finland, appointed by the State Council of Finland, various ministries and governmental central offices, various universities, etc. Even after his retirement, Professor Hokkanen continued his international activities, authorised by the Ministry of Social Affairs and Health, enhancing and co-ordinating the co-operation in science and technology within the field of health and welfare between Japan and Finland from 1989-1995, and between P.R. China and Finland from 1993-1998. Many of these projects involved questions concerning the health of aging populations, where Professor Hokkanen´s expertise in neurology and geriatrics proved valuable.

  • Lee Kudrow (USA)
  • James W Lance Special Recognition Award (Australia) Deceased

    James (Jim) Lance completed his medical degree at the University of Sydney in 1950 and began his clinical work as a Resident Medical Officer at the Royal Prince Alfred Hospital. He took up a National Health and Medical Research Council (NHMRC) fellowship at the University of Sydney in 1952 and was awarded his MD in 1955. In 1954 Professor Lance travelled to London, UK, to train as a neurologist and accepted a position as assistant house physician at the National Hospital in Queen Square. Upon his return to Australia, he combined teaching and clinical practice with appointments as visiting lecturer at the University of Sydney, Superintendent at the Northcott Neurological Centre and Honorary Assistant Physician at Sydney Hospital and St Luke's Hospital.

    Jim Lance left Australia once again in 1960 to follow his passion for research work at the Massachusetts General Hospital in Boston, USA. He returned to Australia as the founder of the department of neurology in the newly established medical school at the University of New South Wales (UNSW), where he remained throughout his professional career starting as senior lecturer, then Associate ProfessorP professor of Neurology - Personal Chair, and finally as Emeritus Professor. To further his research, he continued his clinical practice at the Prince Henry and Prince of Wales Hospitals and was Chairman of the Department of Neurology and Foundation Director of the Institute of Neurological Sciences (INS).

  • Elizabeth A MacGregor Special Recognition Award (UK)

    Anne MacGregor is honorary Professor at the Centre for Neuroscience and Trauma within the Blizard Institute of Cell and Molecular Science at Barts and the London School of Medicine and Dentistry and is a Specialist in Headache and Sexual and Reproductive Healthcare at Barts Health NHS Trust, London, UK.

    She received her medical degree from St Bartholomew’s Hospital, London in 1986. For over 20 years she worked at the City of London Migraine Clinic, initially training under the neurologists Dr Marcia Wilkinson and Dr Nat Blau. In 1999 she became Director of Clinical Research and joined the Board of Directors as Vice Chairman. She was actively involved with the lay headache charities, serving as a trustee of the Migraine Trust and member of the Medical Advisory Board of Migraine Action. She has served on the Executive Boards of the British Association for the Study of Headache and the Anglo-Dutch Migraine Association. For almost a decade she was on the Board of Directors of the International Headache Society, first as Honorary General Secretary and later as Honorary Treasurer.

    Although she has undertaken research in all aspects of primary headaches her interest has focussed on the effects of female sex hormones on headache and her Doctorate Thesis discussed the role of estrogen in migraine. Through her work, she delineated clinical definitions for menstrual migraine, accepted by the International Headache Society. In addition to her work in headache, she is active in the field of education and also sexual and reproductive healthcare and is a Fellow of the Faculty of Sexual and Reproductive Healthcare of the Royal College of Obstetricians and Gynaecologists. She is joint Faculty Deanery Advisor for North East Thames and General Training Programme Director for Barts Health NHS Trust. She is Vice Chair of the Examination committee and Convener of the Critical Reading paper for Membership of the Faculty of Sexual and Reproductive Healthcare. In 2002 she received the Elizabeth Garrett Anderson Award, which was awarded by the World Headache Alliance to a woman who has “made an extraordinary contribution toward relieving the burden of headaches on those affected”.

  • Michael A Moskowitz (USA)

    Michael A Moskowitz, MD, MSc (Hon), FAAN, FAHS is Professor of Neurology at Harvard Medical School and a Member of the Affiliate Faculty of the Harvard-MIT Division of Health Sciences & Technology. He is Board Certified (Neurology, Internal Medicine) and trained at Yale, and at the Harvard-Longwood Neurology Program, respectively followed by 7 years on the Massachusetts Institute of Technology faculty and 31 years at the Massachusetts General Hospital (MGH) in Boston. His research interests focus on translational mechanisms in migraine and stroke. His bibliography includes 505 scientific publications and 45,000 literature citations. Public URL:

    He is listed among the highly cited scientists in Neuroscience. He holds more than a dozen patents and is Director of Stroke and Neurovascular Regulation Laboratory at MGH. He trained more than 100 postdoctoral +6 PhD candidates. His laboratory is credited with discovering the sensory innervation to the circle of Willis (1981), its transmitter tachykinins (1983), and anti-migraine 'triptan' receptors expressed on meningeal afferents (1988-1994). His group is also recognized for demonstrating the importance of neurogenic vasodilation and protein leakage to migraine (1988), and for providing the most technically advanced demonstration of cortical spreading depression in human brain (2001). His laboratory recently provided the first experimental evidence linking cortical spreading depression to trigeminal activation (2002) and provided the first evidence showing that migraine prophylactic drugs suppress cortical spreading depression, as a coherent action (2006). Awards include the Zülch Prize from the Max Planck Society; Thomas Willis Award, American Stroke Association; Decade of the Brain Lecture, American Academy of Neurology; the Ottorino Rossi Award; Bristol-Myers Research Award in Pain and Neuroscience; Soriano Lecturer American Neurological Association among others. He served as Scientific Advisory Board, Chairman, Max-Planck-Institute, Cologne Germany (2000-2006) and for the Humboldt University Berlin Stroke Research Center (2007-2011), and was recently appointed to the LeDuq Foundation SAB. He served as President of the International Society for Cerebral Blood Flow and Metabolism (2001-2003), the President of the IHS, and Board of Directors of the AHS. He was the recipient of the William Silen Award, Harvard Medical School, Lifetime Achievement in Mentoring in 2007. Recently, he was appointed by the Secretary of Health to the Interagency Pain Research Coordinating Committee commissioned by the Institute of Medicine to evaluate pain research portfolios for all USA government agencies (2011-2014).

  • Giuseppe Nappi Special Recognition Award (Italy)

    Giuseppe Nappi MD, Full Professor of Neurology (1986-1998 University of Pavia; 1998-2011 “La Sapienza” University of Rome), is the Scientific Director of the C. Mondino National Neuro-logical Institute in Pavia since 1989. He has been the founder  (in 1971) and subsequently Direc-tor of the Headache Centre at the University of Pavia (Centro Cefalee e Circolazione Encefalica, 1980; University Center / Consortium for Adaptive Disorders and Headache / Head pain = UCADH: 1988/2011 / Headache Science Center, 2009).

    Professor Nappi has been President of the Italian Headache Society (SISC) in the years 1988-1992, of the European Headache Federation (EHF) in 1994-1996, founder/coordinator of the IHS Special Interest Group on Italian Language in 2000-2011, member of the Classification Subcom-mittee of IHS for 1988 and 2004 editions, co-President of IHC Rome 2003. Giuseppe Nappi is Honorary Professor of the Faculty of Medical Sciences at the University of Cordoba in Argentina since 2000 and Member Emeritus of the Research Group on Headache of the World Federation of Neurology since June 27, 2013 (Boston, MA, USA).

    Prof. Nappi’s special research interest’s focus on headache, stroke, aging brain and Parkinson’s disease. In the field of headache he has investigated the role of chronobiological factors in the occurrence of periodic, cyclic headache (Cluster Headache, Menstrual Migraine, Weekend Head-ache), the mechanisms and management of Medication-Overuse Headache (MOH), the mecha-nism of action of symptomatic and prophylactic drugs in Cluster Headache and Migraine, the relationship between migraine, hormones and adaptive disorders/comorbidity, the role of the autonomic nervous system, the role and potentialites of neurophysiological investigations and the utility of animal models of migraine. Prof. Nappi has been the coordinator of COMOESTAS Project (EC, FPVII 2008-2010) and of several research projects supported by the Italian Ministry of Research and Education or by the Italian Ministry of Health.

    Prof. Nappi has authored or co-authored 742 articles in peer reviewed journals (more than half as first author or last author), 135 book chapters, and served as the editor or author of 45 books. His H index is 47.
    He has founded (1986) the International, peer-reviewed Journal ‘Functional Neurology’ and he has acted as Editor-in-chief in the years 1986-2005.

  • Alan M Rapoport (USA)

    Alan Rapoport is a Clinical Professor of Neurology at The David Geffen School of Medicine at the University of California, Los Angeles, where he teaches medical students, neurology residents and fellows. He is also the founder and Director-Emeritus of The New England Center for Headache in Stamford, Connecticut.

    Board-certified in neurology and headache medicine, he has co-authored more than 250 articles, chapters, and posters on headache. He has lectured around the country and internationally to general physicians and headache specialists on all aspects of headache pathophysiology, diagnosis, and treatment and has appeared many times on national radio and television programs, such as Today and Good Morning America.
    Dr Rapoport is an editor of Headache, CNS Drugs, and Editor-in-Chief of Neurology Reviews, and he reviews for many peer-reviewed journals including Cephalalgia, Neurology, New England Journal of Medicine and Headache. He has co-authored nine books on headache for patients, physicians, and nurses with Drs Fred Sheftell and Stewart Tepper. The most recent book, released in 2008, is Conquering Daily Headache, published by BC Decker.

    He is Founder and Chairman of the Board of a non-profit health care company named ProMyHealth. It's goal is to bring medical experts to patients for free and to improve the efficiency and lower the cost of health care.
    Dr Rapoport has served on the Board of Directors of the American Headache Society and is the immediate past President of the Fairfield County Neurological Society, the Founding President of the Headache Cooperative of New England, Founding Director of the Headache Cooperative of the Pacific, and until June 2011 was the Chairman of the Education and Membership Committee of the International Headache Society.

    Speakers Bureau for Depomed
    Consultant for Avanir, Depomed, Dr. Reddy's, Electrocore, Impax, Merck, Teva and Winston

  • K Ravishankar Special Recognition Award (India)

    Dr Ravishankar MD is Consultant in-charge of The Headache and Migraine Clinics at Jaslok Hospital and Lilavati Hospital in Mumbai, India

    He has trained in ‘Headache Management’ first with Dr Ninan Mathew at The Houston Headache Clinic and later with Dr J N Blau at The City of London Migraine Clinic

    Dr Ravishankar has been a member on The Board of Trustees of the International Headache Society from 2008 to 2011, he is a Founder Member of The Asian Headache Foundation and is also a member of The American Headache Society. At The International Headache Congress, 2013 in Boston, he received the Special Recognition Award from the International Headache Society and was also conferred an Honorary Life Membership.

    He is on the Editorial Board of Headache Currents and is a reviewer for ‘Cephalalgia’, ‘Neurology India’ and ‘Annals of The Indian Academy of Neurology’. He has been the Convenor of the Headache Subsection of The Indian Academy of Neurology from 2003 to 2013.

    Dr Ravishankar has been an invited speaker at national and international platforms and has published many articles, has contributed to 10 book chapters and is actively involved in teaching ‘Headache Medicine’ across India. He was also on the Faculty of the IHS Master School in Brazil. He is now into exclusive Headache practice in Mumbai, India.

  • Fumihiko Sakai Special Recognition Award (Japan)

    Fumihiko Sakai obtained his MD in 1969 at the Keio University in Japan. His neurology residency and fellowship was done under Professor Fumio Gotoh in Tokyo, the research on cerebral blood flow in migraine under the supervision of Professor John Stirling Meyer in Houston, USA. His PhD was obtained in 1981 at the Keio University for the study of neurotransmitters and migraine.

    He served as Professor and Chairman of Neurology at the Kitasato University from 1997. Since 2010 he is Professor and Director of the Saitama International Headache Center at the Saitama Neuropsychiatric Institute in Saitama, Japan. He received the 13th and 14th Harold G Wolff Awards, served as President of International Headache Society during 2005-2007 and was Chairman of IHC 2005 in Kyoto, Japan. He is presently President of the Japanese Headache Society.

  • Jean Schoenen (Belgium)

    Jean Schoenen, MD, PhD, gained his medical degree in 1972 from Liège University. For 2 years he was years an International Fogarty Fellow in the Departments of Neurology and Neuropathology of the Massachusetts General Hospital-Harvard Medical School where he obtained certificates in Clinical Neurophysiology and Neuropathology. He has been a board-certified neurologist since 1979 and holds doctoral and post-doctoral degrees from Liège University. He was Research Director of the National Fund for Scientific Research-Belgium and Clinical Professor in Neurology before taking over Full Professorship at Liège University in 1998. He is acting chairman of the Department of Biomedical and Preclinical Sciences at the Faculty of Medicine - Ulg.

    Jean Schoenen's Research has focused on headache and spinal cord anatomy and pathology. He is leading the Headache & Neuronal Regeneration Research Unit and Headache Clinic at Liège University. He has authored 869 publications among which 388 peer-reviewed articles (H index: 54 after 1996), 87 book chapters and four books. He is Associate Editor of Cephalalgia and Editor-in-chief of Acta Neurologica Belgica. He is a former President of the International Headache Society and of the Belgian Neurological Society. He is founding past president of the Belgian Brain Council.

  • Ottar Sjaastad (Norway)
  • Timothy J Steiner Special Recognition Award (UK)
  • K M A Welch (USA)

    On December 2, 2002, Dr K Michael Welch assumed the presidency of Rosalind Franklin University of Medicine and Science. Dr Welch is a neurologist and world-renowned researcher whose career has focused on the study of brain function and structure in cerebrovascular disease, stroke and migraine.

    Dr Welch earned his medical degree at the University of Bristol School of Medicine, United Kingdom and came to the United States in the early 1970s. He held several positions at Baylor College of Medicine (Houston, Texas) including Chief of Neurology at the Ben Taub Hospital before relocating to Michigan in 1981 to become the founding chair of the Department of Neurology at Henry Ford Hospital (HFH), now the Henry Ford Hospital and Health Sciences Center which, as vice president for Academic Affairs, he founded and was instrumental to negotiations that culminated in its academic affiliation with Case Western Reserve University.

    Also at HFH, Dr Welch was director of the NMR Research Center, the Principal Investigator of two NIH-funded centres for stroke and headache research, and the clinician responsible for the overall conduct of the NINDS tissue plasminogen study (the first to establish effectiveness of thrombolysis in acute stroke). He also became the Principal Investigator of the SPARCL trial, the first to establish statin treatment for secondary stroke prevention.

    In 1999 Dr Welch served as Vice Chancellor for Research at the University of Kansas Medical Center and President, Research Institute. He also established the Hoglund Brain Imaging Center at KU and initiated construction of a new sixty million dollar basic science building funded by the Kansas legislature.

    Dr Welch continues to serve NIH as chair of several oversight committees for clinical trials. He has served as Clinical Professor at the University of Michigan, Professor of Neurology at Case Western Reserve University, and as Adjunct Professor at Oakland University and the University of New Mexico.

    Since becoming President of Rosalind Franklin University in 2002, Dr Welch renamed the University and successfully implemented a full institutional assessment that launched a new mission and vision for the university, integrating the education of all health professions with the goal of enhanced delivery of health care into a model of interprofessional education. In 2012 Dr Welch established an Alliance for Health Sciences with DePaul University.

    In July 2006, Dr Welch received an honorary Doctorate of Medicine Degree from his alma mater, the University of Bristol.


You need to be a member of the IHS to access this area of the website, please sign in to continue.

To find out more about membership types and how to join the IHS click onto the 'join' banner on the home page.

Close this box to continue.

Access to the Members Directory is restricted to Standard IHS members

Members Login

Your membership is currently shown as unpaid.

To renew your membership online click HERE.

Otherwise, please contact Carol Taylor to discuss your renewal.

This document is only available to members – please login.